Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process
Pharmaceutics · 07.07.2026 · 18 (7) · 833
DOI: 10.3390/pharmaceutics18070833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.07.2026. Verfasst von Ju-Hyun Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy.
Abstract (Originalsprache)
Background
Amiodarone hydrochloride is an antiarrhythmic agent, primarily classified as a Vaughan Williams Class III antiarrhythmic agent, used for the treatment and prevention of arrhythmia and designated as an essential national drug. Recently, the need to develop formulations suitable for continuous manufacturing, which is gaining significant attention in the pharmaceutical industry, has emerged.
Objective
The objective of this study was to evaluate the formulation potential of amiodarone hydrochloride for the development of an oral tablet, with a specific focus on improving the initial dissolution rate to design a formulation optimized for continuous manufacturing.
Methods
The primary physicochemical properties of amiodarone hydrochloride were predicted and subsequently validated through experimental characterization. Furthermore, the ratios of the binder and granulation liquid were optimized to facilitate robust and successful production via continuous manufacturing.
Results
A new amiodarone hydrochloride tablet formulation, optimized for a continuous wet granulation process, was successfully developed by improving the initial dissolution rate through the optimization of the respective amounts of binder and granulation liquid.
Conclusions
The optimal formulation design established in this research provides a critical foundation for enhancing the applicability of a continuous process in the manufacturing of amiodarone hydrochloride tablets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- College of Pharmacy, Ajou University, 206 World Cup-Ro, Yeongtong-Gu, Suwon 16499, Republic of Korea.
- Department of Biopharmaceutical Chemistry, School of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- Department of Pharmaceutical Engineering, Kookmin University, Seoul 02707, Republic of Korea.
ORCID-Profile: Ju-Hyun Yoon, Young-Joon Park, Joo-Eun Kim
Förderung
- Ministry of Trade, Industry and Energy
Zitieren
APA
Yoon, J. H., Jeon, C. W., Park, Y. J., & Kim, J. E. (2026). Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process. Pharmaceutics, 18(7), 833. https://doi.org/10.3390/pharmaceutics18070833
Vancouver
Yoon JH, Jeon CW, Park YJ, Kim JE. Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process. Pharmaceutics. 2026;18(7):833. doi:10.3390/pharmaceutics18070833
BibTeX
@article{Yoon2026,
author = {Yoon, Ju-Hyun and Jeon, Chae-Won and Park, Young-Joon and Kim, Joo-Eun},
title = {Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {833},
doi = {10.3390/pharmaceutics18070833}
}
EUVIMED